True Relief
Launching a Breakthrough Bioelectronic Therapy for Pain Without Opioids
TrueRelief is a pioneering medical device company delivering a non-invasive, opioid-free bioelectronic therapy designed to relieve pain at its source. With a patented platform and clinical trials underway, TrueRelief offers a breakthrough solution for chronic and acute pain management across multiple therapeutic areas. As a longtime partner, Sagon-Phior helped bring this innovation from idea to launch, providing comprehensive brand, strategy, and marketing support through every phase of the company’s evolution.
Challenge
In a category dominated by pharmaceuticals and invasive treatments, TrueRelief needed to distinguish itself as a safe, science-backed alternative for pain relief — and build credibility with both medical professionals and health-conscious consumers. The brand also needed to prepare for commercialization, including FDA-aligned communications, investor messaging, professional training tools, and marketing tailored to multiple verticals (orthopedics, chiropractic, physical therapy, and consumer wellness).
Solution
Sagon-Phior became an integrated brand and strategy partner, working hand-in-hand with TrueRelief’s founder and stakeholders over multiple stages of product and business development. We provided a full suite of services to prepare the brand for launch and long-term growth, including:
- Brand identity creation and visual system
- Strategic positioning and brand messaging for B2B, B2C, and investor audiences
- Design and development of medical training manuals and provider communications
- Creation of vertical-specific marketing for clinical and retail channels
- UX-driven website development focused on education, trust, and conversion
As TrueRelief evolved, we continuously adapted the messaging and creative assets to align with updated device designs, regulatory requirements, and new market opportunities.
Results
- Brand and messaging alignment across product, clinical, and commercial teams
- Successful pre-launch brand positioning that secured continued investor support
- Strategic marketing infrastructure ready to support FDA clearance, product extensions, and vertical growth
- A trusted brand now positioned at the forefront of non-invasive, non-opioid pain relief technology
